TransMedics Group, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TMDX, updated each market day.
TMDX AI Sentiment
AI predicts TransMedics Group, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About TransMedics Group, Inc. Common Stock
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Sector
Exchange
Market Cap
$3,004,948,065
Cap Tier
Employees
898
Headquarters
ANDOVER, MA
Listed Since
May 2, 2019
Website
TMDX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TMDX Volatility
TransMedics Group, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
